Literature DB >> 19020965

Subunit stoichiometry of the Clostridium botulinum type A neurotoxin complex determined using denaturing capillary electrophoresis.

Michael A Lietzow1, Elizabeth T Gielow, Denise Le, Jifeng Zhang, Marc F Verhagen.   

Abstract

A denaturing capillary electrophoresis method was developed to evaluate the subunit stoichiometry of the Clostridium botulinum type A neurotoxin complex. The results indicate that the neurotoxin complex contains single copies of the 150 kDa neurotoxin and the non-toxic non-hemagglutinating subunits as well as 5-6 HA17, 4-5 HA23, 3-4 HA48, and 8-9 HA34 subunits. The calculated molecular mass for a complex with this stoichiometry is between 880 and 1,000 kDa. The molecular mass of the intact complex was determined using size-exclusion HPLC (SE-HPLC) and SE-HPLC in conjunction with multi-angle laser light scattering detection. Based on a comparison to a mixture of standard proteins, SE-HPLC analysis yielded a molecular mass of 880 kDa while light scattering analysis indicated a weight average molecular mass of 925 +/- 45 kDa. The close agreement between the molecular mass values determined by the three approaches supports the subunit stoichiometry proposed for the C. botulinum type A neurotoxin complex.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19020965     DOI: 10.1007/s10930-008-9151-2

Source DB:  PubMed          Journal:  Protein J        ISSN: 1572-3887            Impact factor:   2.371


  19 in total

1.  AMINO ACID COMPOSITION OF VARIOUS FORMS OF BOVINE AND HUMAN ERYTHROCYTE CARBONIC ANHYDRASE.

Authors:  P NYMAN; S LINDSKOG
Journal:  Biochim Biophys Acta       Date:  1964-04-06

2.  The molecular size and shape of botulinus toxin.

Authors:  G KEGELES
Journal:  J Am Chem Soc       Date:  1946-08       Impact factor: 15.419

3.  The lack of identity between hemagglutinin and the toxin of type A botulinal organism.

Authors:  C LAMANNA; J P LOWENTHAL
Journal:  J Bacteriol       Date:  1951-06       Impact factor: 3.490

4.  Molecular weight and homogeneity of crystalline botulinus A toxin.

Authors:  F W PUTNAM; C LAMANNA; D G SHARP
Journal:  J Biol Chem       Date:  1946-10       Impact factor: 5.157

5.  Botulinum toxin: historical perspective and potential new indications.

Authors:  J Jankovic; M F Brin
Journal:  Muscle Nerve Suppl       Date:  1997

6.  Amino acid composition of crystalline botulinum toxin, type A.

Authors:  D Stefanye; E J Schantz; L Spero
Journal:  J Bacteriol       Date:  1967-07       Impact factor: 3.490

7.  Complete DNA sequences of the botulinum neurotoxin complex of Clostridium botulinum type A-Hall (Allergan) strain.

Authors:  Li Zhang; Wei-Jen Lin; Shengwen Li; K Roger Aoki
Journal:  Gene       Date:  2003-10-02       Impact factor: 3.688

8.  Molecular construction of Clostridium botulinum type A toxins.

Authors:  S Sugii; G Sakaguchi
Journal:  Infect Immun       Date:  1975-12       Impact factor: 3.441

9.  Separation of the components of type A botulinum neurotoxin complex by electrophoresis.

Authors:  S K Sharma; M A Ramzan; B R Singh
Journal:  Toxicon       Date:  2003-03-01       Impact factor: 3.033

10.  Molecular composition of Clostridium botulinum type A progenitor toxins.

Authors:  K Inoue; Y Fujinaga; T Watanabe; T Ohyama; K Takeshi; K Moriishi; H Nakajima; K Inoue; K Oguma
Journal:  Infect Immun       Date:  1996-05       Impact factor: 3.441

View more
  15 in total

1.  Duration of action of abobotulinumtoxina and onabotulinumtoxina: a randomized, double-blind study using a contralateral frontalis model.

Authors:  Mark S Nestor; Glynis R Ablon
Journal:  J Clin Aesthet Dermatol       Date:  2011-09

2.  Comparative evaluation of the potency and antigenicity of two distinct BoNT/A-derived formulations.

Authors:  M Brown; G Nicholson; M C Ardila; A Satorius; R S Broide; K Clarke; T Hunt; J Francis
Journal:  J Neural Transm (Vienna)       Date:  2012-07-29       Impact factor: 3.575

Review 3.  Assembly and function of the botulinum neurotoxin progenitor complex.

Authors:  Shenyan Gu; Rongsheng Jin
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

4.  Molecular composition and extinction coefficient of native botulinum neurotoxin complex produced by Clostridium botulinum hall A strain.

Authors:  Anne-Marie Bryant; Jenny Davis; Shuowei Cai; Bal Ram Singh
Journal:  Protein J       Date:  2013-02       Impact factor: 2.371

5.  Content of botulinum neurotoxin in Botox®/Vistabel®, Dysport®/Azzalure®, and Xeomin®/Bocouture®.

Authors:  Jürgen Frevert
Journal:  Drugs R D       Date:  2010

6.  Complexing proteins in botulinum toxin type A drugs: a help or a hindrance?

Authors:  Jürgen Frevert; Dirk Dressler
Journal:  Biologics       Date:  2010-12-09

Review 7.  Bacterial toxins and the nervous system: neurotoxins and multipotential toxins interacting with neuronal cells.

Authors:  Michel R Popoff; Bernard Poulain
Journal:  Toxins (Basel)       Date:  2010-04-15       Impact factor: 4.546

8.  Pharmaceutical, biological, and clinical properties of botulinum neurotoxin type A products.

Authors:  Jürgen Frevert
Journal:  Drugs R D       Date:  2015-03

9.  Triple-Blind, Prospective, Internally Controlled Comparative Study Between AbobotulinumtoxinA and OnabotulinumtoxinA for the Treatment of Facial Rhytids.

Authors:  Ramtin Kassir; Aparanjita Kolluru; Martin Kassir
Journal:  Dermatol Ther (Heidelb)       Date:  2013-08-16

Review 10.  Immunogenicity of botulinum toxins.

Authors:  Markus Naumann; Lee Ming Boo; Alan H Ackerman; Conor J Gallagher
Journal:  J Neural Transm (Vienna)       Date:  2012-09-25       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.